These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 16699174)

  • 1. The necessity of a human epigenome project.
    Esteller M
    Carcinogenesis; 2006 Jun; 27(6):1121-5. PubMed ID: 16699174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
    Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
    Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.
    Clark SJ
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R88-95. PubMed ID: 17613553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer epigenome.
    Lechner M; Boshoff C; Beck S
    Adv Genet; 2010; 70():247-76. PubMed ID: 20920751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic mechanisms in glioblastoma multiforme.
    Nagarajan RP; Costello JF
    Semin Cancer Biol; 2009 Jun; 19(3):188-97. PubMed ID: 19429483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
    Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
    Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic changes in solid and hematopoietic tumors.
    Toyota M; Issa JP
    Semin Oncol; 2005 Oct; 32(5):521-30. PubMed ID: 16210093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epigenetics of oral cancer.
    Shaw R
    Int J Oral Maxillofac Surg; 2006 Feb; 35(2):101-8. PubMed ID: 16154320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fundamental role of epigenetics in hematopoietic malignancies.
    Galm O; Herman JG; Baylin SB
    Blood Rev; 2006 Jan; 20(1):1-13. PubMed ID: 16426940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation.
    Jacinto FV; Ballestar E; Esteller M
    Oncogene; 2009 Nov; 28(47):4212-24. PubMed ID: 19734945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors.
    Fraga MF; Herranz M; Espada J; Ballestar E; Paz MF; Ropero S; Erkek E; Bozdogan O; Peinado H; Niveleau A; Mao JH; Balmain A; Cano A; Esteller M
    Cancer Res; 2004 Aug; 64(16):5527-34. PubMed ID: 15313885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic changes in prostate cancer: implication for diagnosis and treatment.
    Li LC; Carroll PR; Dahiya R
    J Natl Cancer Inst; 2005 Jan; 97(2):103-15. PubMed ID: 15657340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene silencing by DNA methylation in haematological malignancies.
    Boultwood J; Wainscoat JS
    Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epigenome and cancer: new possibilities of cancer prevention and therapy?].
    Paluszczak J; Baer-Dubowska W
    Postepy Biochem; 2005; 51(3):244-50. PubMed ID: 16381168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Momentum building for human epigenome project.
    Garber K
    J Natl Cancer Inst; 2006 Jan; 98(2):84-6. PubMed ID: 16418505
    [No Abstract]   [Full Text] [Related]  

  • 16. CpG island mapping by epigenome prediction.
    Bock C; Walter J; Paulsen M; Lengauer T
    PLoS Comput Biol; 2007 Jun; 3(6):e110. PubMed ID: 17559301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth.
    Hong C; Moorefield KS; Jun P; Aldape KD; Kharbanda S; Phillips HS; Costello JF
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):10974-9. PubMed ID: 17578925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting aberrant chromatin structure in colorectal carcinomas.
    Konishi K; Issa JP
    Cancer J; 2007; 13(1):49-55. PubMed ID: 17464246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
    Vaissière T; Sawan C; Herceg Z
    Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future potential of the Human Epigenome Project.
    Eckhardt F; Beck S; Gut IG; Berlin K
    Expert Rev Mol Diagn; 2004 Sep; 4(5):609-18. PubMed ID: 15347255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.